Myriad Genetics | MYGN - Trade Debtors


Myriad Genetics reported $115.3M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.5B 23M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Bio-Rad Laboratories USD 460.6M 4.1M Dec/2025
Bruker USD 542.7M 2.2M Mar/2026
Danaher USD 4.76B 845M Mar/2026
Illumina USD 738M 116M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Mettler Toledo International USD 708.21M 70.04M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
OraSure Technologies USD 22.2M 2.1M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Quest Diagnostics USD 1.59B 179M Mar/2026
Quidel USD 359.9M 57.1M Mar/2026
Repligen USD 151.55M 7.03M Mar/2026
Revvity USD 691.38M 53.29M Mar/2026
Standard Biotools USD 13.43M 109K Dec/2025
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Veracyte USD 50.11M 5.45M Mar/2026
Waters USD 1.76B 930.16M Mar/2026